Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women

Summary

A case control trial Patients who meet the inclusion criteria were asked to participate in the study and a written consent was obtained from each patient after explaining thoroughly the nature and the scope of the study. Patients were divided into three equal groups: Group A: included 40 pregnant patients. They received two ml of normal saline intravenously as a placebo. Group B: included 40 pregnant patients. They received (20mg) hyoscine butylbromide (one ml HBB+ one ml saline) intravenously. Group C: included 40 pregnant patients .They received two ml (40 mg) hyoscine butylbromide intravenously (HBB).

Timeline

Start

2017-02-11

Primary completion

2022-01-10

Completion

2022-02-03

Drugs

Indications

No indication recorded.